The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
Open accessAbstract
Consumption of fructose has risen markedly in recent decades owing to the use of sucrose and high-fructose corn syrup in beverages and processed foods 1, and this has contributed to increasing rates of obesity and non-alcoholic fatty liver disease 2-4. Fructose intake triggers de novo lipogenesis in the liver 4-6, in which carbon precursors of acetyl-CoA are converted into fatty acids. The ATP citrate lyase (ACLY) enzyme cleaves cytosolic citrate to generate acetyl-CoA, and is upregulated after consumption of carbohydrates 7. Clinical trials are currently pursuing the inhibition of ACLY as a treatment for metabolic diseases 8. However, the route from dietary fructose to hepatic acetyl-CoA and lipids remains unknown. Here, using in vivo isotope tracing, we show that liver-specific deletion of Acly in mice is unable to suppress fructose-induced lipogenesis. Dietary fructose is converted to acetate by the gut microbiota 9, and this supplies lipogenic acetyl-CoA independently of ACLY 10. Depletion of the microbiota or silencing of hepatic ACSS2, which generates acetyl-CoA from acetate, potently suppresses the conversion of bolus fructose into hepatic acetyl-CoA and fatty acids. When fructose is consumed more gradually to facilitate its absorption in the small intestine, both citrate cleavage in hepatocytes and microorganism-derived acetate contribute to lipogenesis. By contrast, the lipogenic transcriptional program is activated in response to fructose in a manner that is independent of acetyl-CoA metabolism. These data reveal a two-pronged mechanism that regulates hepatic lipogenesis, in which fructolysis within hepatocytes provides a signal to promote the expression of lipogenic genes, and the generation of microbial acetate feeds lipogenic pools of acetyl-CoA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“an animal study found that dietary fructose could be converted to microbial acetate by the gut microbiota, which may enhance hepatic lipogenesis by supplying lipogenic acetyl-CoA independently of ATP citrate lyase.96”
From Dietary sugar consumption and health: umbrella review (2023) · cites this paper as [96]
The cited source says what the claim attributes to it.
In the citing paper
“In mice, dietary fructose is metabolized by gut microbes into acetate, serving as a source of acetyl-CoA for lipid synthesis [61].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Chong, J., Soufan, O., Li, C., Caraus, I., Li, S., Bourque, G., Wishart, D. S., & Xia, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky310 · Cited by 3,637
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity
Bray, G. A., Nielsen, S. J., & Popkin, B. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.537 · Cited by 1,990
Nadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,931
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069
Donohoe, D. R., Collins, L. B., Wali, A., Bigler, R., Sun, W., & Bultman, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.033 · Cited by 993
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S. A., Nadeau, K. J., Cree‐Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 993
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Softic, S., Cohen, D. E., & Kahn, C. R. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4054-0 · Cited by 709
The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids
Jang, C., Hui, S., Lu, W., Cowan, A. J., Morscher, R. J., Lee, G., Liu, W., Tesz, G. J., Birnbaum, M. J., & Rabinowitz, J. D. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.016 · Cited by 639
Self-citation
Cited by
Sorted by citations
Items 401–500 of 577
Wu, K., Yu, H., Cao, K., Dai, B., Yuan, Y., Qian, X., Zhong, H., Qu, Y., Jiang, H., & Chen, T. W. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2642459 · Cited by 4
The Gut Microbiota: An Essential Component in Understanding Pediatric Obesity: A Narrative Review
Lupu, V. V., Nedelcu, A. H., Balas, R. B., Anton, C., Tarnita, I., Azoicai, A. N., Forna, L., Munteanu, D., Anton, S. C., Shawais, S. K., et al. (2026) · Nutrients · doi:10.3390/nu18060952 · Cited by 3
Wang, Y., Kang, A.-Q., Wang, S., Yang, Z., Liu, H., Yue, L., Li, H., Wu, C., Ren, W., Miao, X.-L., et al. (2026) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2026.156597 · Cited by 3
Wang, G., Li, M., Wang, Y., Wang, B., Pu, H., Mao, J., Zhang, S., Zhou, S., & Luo, P. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.998796 · Cited by 3
Bile acids mediate fructose-associated liver tumour growth in mice
Hargett, S. R., Lahiri, S., Kowalski, G. M., Corley, S., Nelson, M. E., Lackner, C., Olzomer, E. M., Aleksovska, I., Hearn, B. A., Shrestha, R., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167029 · Cited by 3
Chen, X., Xu, Q., Ding, W., Wang, Y., Wang, P., Zhao, C., Ao, X., & Wang, J. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10657-4 · Cited by 3
de Sandy-Galán, D. A. D., Villamil‐Ramírez, H., Rodríguez‐Cruz, M., López-Contreras, B. E., León‐Mimila, P., Olivares-Arévalo, M., Maldonado‐Hernández, J., Domínguez-Calderón, I., Salmerón, J., Cerqueda‐García, D., et al. (2025) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/6652392 · Cited by 4
“…hepatic lipogenesis and metabolic syndrome [37], while increased SCFA production in response to soluble fber supplementation (inulin) conferred a higher risk of hepatocellular carcinoma [38] and dietary fructose enhanced hepatic lipogenesis through microbiota-derived acetate in a murine model [39].”
Fructose metabolism by the guts cuts liver fat
Helsley, R. N., & Softic, S. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01912-z · Cited by 3
Tsoukalas, D., Sarandi, E., & Thanasoula, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-64969-2_13 · Cited by 4
Nonalcoholic liver disease: review with a focus on risks of progression
Teplyuk, D. A., Semenistaya, M. C., Sorokoletov, S. M., Лазебник, Л. Б., & Pavlov, C. S. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-192-8-167-174 · Cited by 3
Li, F., Zhu, L.-L., Gao, L., Pan, Y. H., Han, B., & Kong, L.-D. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105632 · Cited by 3
Sánchez-Terrón, G., Martínez, R., Delgado, J., Molina, J., & Estévez, M. (2024) · Food Research International · doi:10.1016/j.foodres.2024.114769 · Cited by 3
Yang, Y., Wang, X., & Yang, W. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.10.029 · Cited by 3
Wang, X., Li, M., Fang, Y., Hou, L., Cao, R., Zhang, L., Xie, J., Wang, F., & Huang, J. (2024) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-024-01046-7 · Cited by 3
Fructose Metabolism and Acute Myeloid Leukemia
Kansal, R. (2021) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2021.00042 · Cited by 3
Yenilmez, B., Kelly, M., Zhang, G., Wetoska, N., Ilkayeva, O., Min, K., Rowland, L. A., DiMarzio, C., He, W., Raymond, N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.21.485183 · Cited by 3
“This concept is consistent with work indicating a major role for acetate in liver lipogenesis as recently published by others using different mouse models (34, 56, 57).”
BackgroundResultInfluentialIntegrated multi-cohort analysis of the Parkinson’s disease gut metagenomePreprint
Boktor, J. C., Sharon, G., Metman, L. V., Hall, D. A., Engen, P. A., Zreloff, Z. J., Hakim, D., Bostick, J. W., Ousey, J. A., Lange, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.20.500694 · Cited by 3
Blachier, F. (2023) · Springer eBooks · doi:10.1007/978-3-031-26322-4_5 · Cited by 2
Turner, R., Mukherjee, R., Wallace, M., & Sánchez-Gurmaches, J. (2023) · Journal of Visualized Experiments · doi:10.3791/64219 · Cited by 2
Mohammed, M. A., Hay, N. H. A., Mohammed, M. T., Mahmoud, H. S., Ahmed, M. Y., Abdelmenem, A., & Abdelrahim, D. S. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03518-5 · Cited by 2
“Hepatic lipogenesis induced by fructose seems to be related to acetate derived from microbiota (Zhao et al. 2020).”
Chen, L., Song, Y., Huang, Y., Hu, J., Meng, Y., Yuan, M., Zheng, G., Wang, X., Zhang, C., & Qiu, Z. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70425 · Cited by 2
“A key study published in Nature (2020) suggested that dietary fructose metabolized in the small intestine could be converted into acetate by gut microbiota, triggering lipid synthesis independently of ACLY (Zhao et al. 2020).”
InfluentialWu, B., Lin, H.-L., Su, H. C., Cheng, P., Ya-Mei, C. H. E. N., Hao, C., & Shen, K. (2025) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.71.321 · Cited by 2
Cai, K., Chen, Z., Wu, J., Wang, Q., Zhou, X., Pan, B., Xie, Z., Li, P., Chen, F., Chen, H., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01237-4 · Cited by 2
“Previous studies have shown that NAFLD not only damaged the liver but also destroyed the intestinal barrier function of the small intestine, increasing the accumulation of the fat-produced cells [37, 38].”
Intestine-derived sorbitol drives steatotic liver disease in the absence of gut bacteria
Jackstadt, M. M., Fowle-Grider, R., Song, M.-G., Ward, M. H., Barr, M., Cho, K., Palacios, H. H., Klein, S., Shriver, L. P., & Patti, G. J. (2025) · Science Signaling · doi:10.1126/scisignal.adt3549 · Cited by 3
Behrens, J., Fuh, M. M., Haas, D. T., Jaeckstein, M. Y., Heine, M., Siebels, B., Worthmann, A., Krahmer, N., Heeren, J., & Scheja, L. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025229 · Cited by 2
“T [20 mM Tris, 150 mM NaCl, 0.1% (v / v) Tween 20].”
InfluentialMa, J., Song, N., Huang, N., Rong, Z., Li, J., Wang, S., Zhang, X., Wei, Q., & Chen, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-30526-z · Cited by 2
“Studies have shown that the reduction in lipid hydrolysis may be associated with a negative feedback regulatory mechanism triggered by increased intestinal lipid absorption, thereby suppressing hepatic lipid synthesis 59 .”
AR-CDT NET: a deep deformable convolutional network for gut microbiome-based disease classification
Li, J., Sun, Z., Chai, S., Li, H.-J., Wang, Y., & Tian, J. (2025) · BMC Bioinformatics · doi:10.1186/s12859-025-06357-0 · Cited by 2
“We hypothesize that in the context of a diet driving NAFLD, this reflects an over-fermentation that produces an imbalanced SCFA profile, where acetate and propionate can serve as substrates for hepatic de novo lipogenesis (DNL) and thus exacerbate fat accumulation in the liver [31].”
Takahashi, H., Harada, N., Hayamizu, Y., Dungubat, E., Nakazawa, M., Kitakaze, T., Sugimoto, K., INUI, H., YOSHIHARA, E., Takahashi, Y., et al. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00518.2025 · Cited by 2
Nutrient-driven histone acetylation underlies energy storage and mobilization
Chen, L., Zhu, L., Xiao, H., Wang, X., Xia, F., Wang, Z., Wu, L., Wu, D., Liu, Q., Cheng, J., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102344 · Cited by 2
Substrate supply, compartmentation, and utilization in hepatic de novo lipogenesis
Pape, D. J., & Taylor, E. B. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.01.001 · Cited by 2
Molecular mechanisms and pathogenesis of MASH
Gallage, S., Govaere, O., Anstee, Q. M., Shulman, G. I., Tacke, F., & Heikenwälder, M. F. (2026) · Nature · doi:10.1038/s41586-026-10529-0 · Cited by 3
“Moreover, fructose causes intestinal-barrier deterioration and endotoxaemia, which in turn has been shown to lead to induction of hepatic lipogenic enzyme expression through activation of myeloid cell MyD88 and TNF production 142,143 .”
Strober, J. W., Fernandez, S., Ye, H., & Brady, M. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00174.2021 · Cited by 2
Self-citationPolycystic ovarian syndrome and microbiome: Implications for women’s health
Patel, N., Singh, D., Lokary, V., & Shaker, I. A. (2023) · Journal of Medical and Scientific Research · doi:10.17727/jmsr.2023/11-10 · Cited by 2
Unveiling strain-level dynamics in probiotic activity
Chang, J., Wu, Y., & Wu, H. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.11.009 · Cited by 2
Physiological consequences of Aldolase C deficiency during lactation
Votava, J. A., Fan, J., & Parks, B. W. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315719 · Cited by 2
“In tissues performing large amounts of DNL, citrate is transported out of the mitochondria to the cytosol and converted back into acetyl-CoA and oxaloacetate via the enzyme ATP-citrate lyase ( Acly ) [8].”
Feng, L., Xu, Q., Feng, J., Wang, Y., Li, S., Zhang, Q., Zhou, L., & Xu, J. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.742522 · Cited by 2
Suárez‐Sánchez, F., Pérez-Ruiz, E., Ramírez‐Silva, C. I., Molina-Ayala, M., Rivera-Gutiérrez, S., León-Solís, L. E., García-Morales, L., Rodríguez-González, A., Martínez-Ortiz, C. A., Meneses-Tapia, L. A., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1613221 · Cited by 2
Commensal Microbes and Their Metabolites: Influence on Host Pathways in Health and Cancer
Méndez, R., Banerjee, S., & Banerjee, S. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_10 · Cited by 1
Topic: Nutrition and the Gut-Liver-Brain Axis
Ho, A. H. Y., Wong, S. H., & Lui, R. N.-S. (2022) · Current Hepatology Reports · doi:10.1007/s11901-022-00589-x · Cited by 3
Verma, A., Mittal, R., Navaneethakannan, M., Ahirwar, S. S., Mukherjee, S., & Kotnis, A. L. (2024) · Current Molecular Medicine · doi:10.2174/0115665240269082240213115711 · Cited by 2
Ting, K. K. Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1407108 · Cited by 2
“Apart from this, it is also important to highlight that recent research has shown that acetate secreted by gut microbes post excess fructose metabolism can also contribute to the lipogenic pools of acetyl-CoA in hepatocytes (59).”
BackgroundCharifi, W., Fauveau, V., Francese, L., Grosfeld, A., Gall, M. L., Ourabah, S., Ellero‐Simatos, S., Viel, T., Caüzac, M., Gueddouri, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.18.444615 · Cited by 2
Fadhul, T., Park, S., Ali, H., Alsiraj, Y., Wali, J. A., Simpson, S. J., & Softic, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.26.625441 · Cited by 2
The ATO gene family governs Candida albicans colonisation in the dysbiotic gastrointestinal tractPreprint
Alves, R. M. A., Ghasemi, F., Genechten, W. V., Wijnants, S., Goethem, O. V., Barata-Antunes, C., Fernandes, V., Ataíde, P., Gomes-Gonçalves, A., Vergauwen, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.29.656788 · Cited by 2
Diet Modulates Gut Microbiome and Metabolites in Non-alcoholic Fatty Liver Diseases
Pan, Y., & Zhang, X. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_9 · Cited by 1
Discovery of Alkyl Conjugated Diene Diacids as Novel ACLY Inhibitors
Cheng, T., Song, G., Cheng, L., Wang, F., Sun, X., Xie, Z., Zhang, M., Zhang, Y., Li, J., & Nan, F. (2024) · Chinese Journal of Organic Chemistry · doi:10.6023/cjoc202405036 · Cited by 1
Zhang, B., Li, Y., Li, Y., Song, J., Fang, Y., Na, Z., & Li, D. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07415-4 · Cited by 1
“It undergoes hepatic metabolism [11], contributing to ATP depletion, thus facilitating lipid synthesis [12], and triggering oxidative stress [13].”
The gut microbiome and nonalcoholic fatty liver disease: prospects for drug therapy
Teplyuk, D. A., Levina, O. N., Pavlov, C. S., Sorokoletov, S. M., Pashkova, E. Y., As, A., Bolshakov, S. A., & Shutov, E. V. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-230-10-178-187 · Cited by 1
Sun, Y., Cui, F., Tang, S., Li, P., Xu, Y., Li, H., Wang, Y., Li, X., Zhang, M., Ma, R., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1655026 · Cited by 1
O‐GlcNAcylation Facilitates the Initiation and Progression of Digestive Tumors
Xiong, Y., Hu, Q., Li, D., Yan, J., Yang, J., Wang, Y., Cao, H., Liu, Y., Xia, Y., Zhang, F., et al. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70093 · Cited by 1
“This acetate is subsequently converted to acetyl-CoA in the liver [66].”
Yao, T., Xiong, Y., Hu, Q., Chen, Y., Li, D., Yan, J., Yang, J., Wang, Y., Cao, H., Zhang, F., et al. (2026) · BMC Microbiology · doi:10.1186/s12866-025-04591-3 · Cited by 1
“Excessive fructose intake, for instance, leads to microbial acetate overproduction, promoting obesity and non-alcoholic fatty liver disease [65].”
Gawin, K., Tuśnio, A., Barszcz, M., Taciak, M., Święch, E., Konopka, A., Frączek, N., Szumska, M., & Pastuszewska, B. (2026) · BMC Veterinary Research · doi:10.1186/s12917-025-05266-x · Cited by 1
“It is well recognized for its role in lipogenesis in the liver and adipose tissue [88] but some research has also demonstrated its protective role against obesity [89].”
Lactobacillus murinus Alleviates High Fructose‐Induced MASLD by Boosting Arginine Production
Mo, X., Zhao, G., Liu, L., Zhen, L., Huang, Q. Y., Wang, Y., Yang, X., Huang, L., Wan, L., Wei, C., et al. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71502 · Cited by 1
“Emerging evidence indicated that gut microbiota-mediated conversion of dietary fructose to acetate fuels lipogenic acetyl-CoA pools, exacerbating hepatic DNL. Microbiota depletion effectively suppressed fructose-driven conversion of hepatic acetyl-CoA and fatty acids (Zhao et al. 2020).”
Wang, X., Zhang, A., Yu, C., Tang, X., Wang, J., Chen, F., Jiang, K., Yin, W., & Fang, W. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117371 · Cited by 1
Yin, Q., Yang, J., Xu, Y., Qi, Z., Wang, X., Zhu, X., Jing, Y. J., Chen, J., Min, J., Lu, H., et al. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168336 · Cited by 1
Metabolic Dysfunction‐Associated Fatty Liver Disease: From Pathogenesis to Treatment
Cui, Z., Du, X., Amevor, F. K., Xia, Y., Yang, Y., & Liu, L. (2026) · MedComm · doi:10.1002/mco2.70832 · Cited by 1
“Reduced Lactobacillus reuteri abundance in HCC was associated with decreased SCFA levels, particularlyacetate [ 281 ], which plays a regulatory role in hepatic lipogenesis [ 282 ].”
Gut Microbiota and Metabolic Syndrome: A Narrative Review
Kotsiri, I., Prokou, M., Domazinaki, C.-M., Papadakaki, E., & Magiorkinis, E. (2026) · Biology · doi:10.3390/biology15141115 · Cited by 1
“The rate of fructose intake appears to be important, as gradual consumption favors absorption in the small intestine and may involve both classical and alternative pathways in lipogenesis [51].”
InfluentialEun, J. W., Cheong, J. Y., & Kim, S. S. (2026) · Journal of Korean Medical Association · doi:10.5124/jkma.26.0074 · Cited by 1
A gut microbial odd-chain fatty acid alleviates atherosclerosis in mice
Yin, C., Chen, Y., Lin, G., Cai, M., Pang, C., Xiao, X., Han, K., Mei, C., Qin, M., 范培芝, et al. (2026) · Nature · doi:10.1038/s41586-026-11142-x · Cited by 2
Reconciling host-microbiota metabolic incompatibility safeguards male fertility
Shang, Q., Li, Z., Yin, N., & Peng, M. (2024) · hLife · doi:10.1016/j.hlife.2024.04.006 · Cited by 2
“For experiments with antibiotics, 1 g/L ampicillin, 1 g/L metronidazole, 1 g/L neomycin, and 0.5 g/L vancomycin were dissolved in regular drinking water [35].”
InfluentialZheng, S., Barczak, W., Liu, G., & Thangue, N. B. L. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-00228 · Cited by 1
Ryskova, L., Pospíšilová, K., Vávra, J., Wolf, T., Dvořák, A., Vı́tek, L., & Polak, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-79458-0 · Cited by 1
Decoding MASLD’s Pathophysiology
Abenavoli, L., & Scarlata, G. G. M. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_3 · Cited by 1
Surprising findings in a ‘well-understood’ nutrient-assimilation pathway
Hellerstein, M. K. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0242-5 · Cited by 1
Research of liver bacteria and lipid profiles on Shaziling pigs
Ma, J., Duan, Y., Li, F., Li, T., Yin, J., & Yin, Y. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0060 · Cited by 1
Liao, Y., Liu, L., Li, H., Bai, X., Sun, F., Xiao, X., & Fu, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.08.443229 · Cited by 1
Integrating Multi-Omics Reveals Crucial Biomarkers in Non-Alcoholic Fatty Liver DiseasePreprint
Zeng, Y., Wang, X., He, H., Yang, L., Li, S., & An, Z. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3915431 · Cited by 1
Zhi, D., Ye, X., Fu, H., Li, J., Ding, J., Ren, G., Zhou, L., Pi, X., & Miao, J. (2023) · Preprints.org · doi:10.20944/preprints202303.0205.v1
Echeverría, C. E., Ahmed, M., Gao, J., Stewart, S. L., Nathoo, I., Debarba, L. K., Lafourcade, C., Ahmed, T., Shamieva, O., Perrier, T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.03.729910 · Cited by 1
Blocking Fructose could be a Novel Approach against Cancer
Nakagawa, T., Lanaspa, M. A., Andres-Hern, A., Kojima, H., & Johnson, R. J. (2020) · Journal of Clinical & Experimental Nephrology
Diet’s impact dictated by synonymous mitochondrial SNP interacting with nucleotypePreprint
Dobson, A. J., Voigt, S., Kumpitsch, L., Langer, L., Voigt, E., Ibrahim, R., Dowling, D. K., & Reinhardt, K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.07.434274
Radiometric Evaluation of Mandibular Ramus for Gender Determination
Sharma, A., Singal, K., Singh, P., & Sharma, N. K. (2024) · HAL · doi:10.5281/zenodo.12772711
The price of “health”: Herbalife® and Juice Plus+® products under study
Aranda, A. G. (2021) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Huang, H., Li, M., Wang, Y., Wu, X., Wang, Q., Shen, J., Xiao, Z., Zhao, Y., Du, F., Li, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-683396/v1
Genetic Variation in Sugar Metabolism Confers a Protective Metabolic Profile
Le, J., & Jang, C. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.01.006
Self-citationChung, H. (2022) · Hepatology · doi:10.1002/hep.32310
“In patients with genotype 1a infection, the presence of baseline NS5A resistance associate substitutions (RASs) that cause a large reduction in the activity of NS5A inhibitors (>5 fold) adversely affects response to some NS5A inhibitor– containing regimens.[3] Approximately 10% of patients in both groups had baseline…”
BackgroundDewi, D. A. A. P., Estuningtyas, A., & Purwaningsih, E. H. (2022) · Journal of Southwest Jiaotong University · doi:10.35741/issn.0258-2724.57.1.39
Sucrose: Dietary sucrose and disease
Gerber, P. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821848-8.00107-4
Telomere dysfunction impairs intestinal differentiation and predisposes to diet-induced colitisPreprint
Engevik, M. A., Guo, L., Song, W., Chronowski, C., Akhanov, V., Huerta, N. A. B., Engevik, A. C., Oezguen, N., Coarfa, C., Putluri, N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.14.499988
Self-citationThe role of fatty acids metabolism on cancer progression and therapeutics development
Moreira-Barbosa, C., Matos, A., Fernandes, R., Mendes-Ferreira, M., Rodrigues, R. C., Cruz, T., Costa, Â. M., Cardoso, A. P., Ghilardi, C., Oliveira, M. J., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824043-4.00007-5
Heyens, L. J. M., Bauer, J., & Koek, G. H. (2022) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.78.22.106
Fang, J., Chen, J., Zheng, J.-L., Zeng, H.-X., Chen, J.-G., Wu, C.-H., Cai, J.-L., Wang, Z., & Zhuang, S. (2023) · doi:10.1158/0008-5472.c.6599617.v1
Brouns, F. J. P. H. (2023) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2868-0_10
Progress on the Role of “Gutbacteria-Gut-Liver Axis” in Non-Alcoholic Fatty Liver Disease
陈, 孟. (2023) · Medical Diagnosis · doi:10.12677/md.2023.132038
Ibrahim, K. G., Chivandi, E., Erlwanger, K. H., & Brooksbank, R. L. (2023) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2022-0528
Park, S., Fadhul, T., Conroy, L. R., Clarke, H. A., Sun, R. C., Wallenius, K., Boucher, J., O’Mahony, G., Boianelli, A., Persson, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.14.553218
“37 REFERENCES Abdelmalek, M.F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R.J., Diehl, A.M., and Nonalcoholic Steatohepatitis Clinical Research, N. (2010). Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51, 1961-1971. A…”
BackgroundInfluentialHepatic Safety in Rats Fed on Fructose, Glucose, or Sucrose When Combine with A Moderate Fat Diet
Nasr, N., Elkattawy, A. M., Kahilo, K. A., Sadek, K. M., Elhady, S. A., El-Sawy, H. B., & Dorghamm, D. A. (2023) · Egyptian Journal of Veterinary Science · doi:10.21608/ejvs.2023.230165.1563
“It is actually well-known that sugar boosts de novo synthesis of free fatty acids (FFA) in the liver [37,38].”
Backgroundde Souza, J. G. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2023.tde-30102023-162135
Song, M., Yuan, F., Li, X., Ma, X., Yin, X., Rouchka, E. C., Zhang, X., Deng, Z., Prough, R. A., & McClain, C. J. (2021) · Figshare · doi:10.6084/m9.figshare.13532740
Song, M., Yuan, F., Li, X., Ma, X., Yin, X., Rouchka, E. C., Zhang, X., Deng, Z., Prough, R. A., & McClain, C. J. (2021) · Figshare · doi:10.6084/m9.figshare.13532725
Song, M., Yuan, F., Li, X., Ma, X., Yin, X., Rouchka, E. C., Zhang, X., Deng, Z., Prough, R. A., & McClain, C. J. (2021) · Figshare · doi:10.6084/m9.figshare.13532731
Song, M., Yuan, F., Li, X., Ma, X., Yin, X., Rouchka, E. C., Zhang, X., Deng, Z., Prough, R. A., & McClain, C. J. (2021) · Figshare · doi:10.6084/m9.figshare.13532743
Song, M., Yuan, F., Li, X., Ma, X., Yin, X., Rouchka, E. C., Zhang, X., Deng, Z., Prough, R. A., & McClain, C. J. (2021) · Figshare · doi:10.6084/m9.figshare.13532734
Song, M., Yuan, F., Li, X., Ma, X., Yin, X., Rouchka, E. C., Zhang, X., Deng, Z., Prough, R. A., & McClain, C. J. (2021) · Figshare · doi:10.6084/m9.figshare.13532728
Song, M., Yuan, F., Li, X., Ma, X., Yin, X., Rouchka, E. C., Zhang, X., Deng, Z., Prough, R. A., & McClain, C. J. (2021) · Figshare · doi:10.6084/m9.figshare.13532737
The role of short-chain fatty acids in the progression of non-alcoholic fatty liver disease
Сергеевна, К. Т., Livzan, M. A., & Syrovenko, M. I. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-009
Drug Discovery for Chromatin Readers, Writers, Erasers, Remodelers and Epitranscriptomic Targets
(2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-part3
Human microbiome, obesity and cardiovascular diseases
Piansay‐Soriano, M. E., Soriano, S. K., Pague, B. V., Platero, M. S., Candelario-Plata, M. A., & Calunsag, M. K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15435-5.00008-6
The Role of the Intestinal Microbiota in NAFLD Onset and Progression
Pinheiro, I. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007741
Bisphenol F exposure induced vascular toxicity through intestinal microbiota imbalance
Yan, J., Pan, Y., Liu, H., Yuan, J. X., Chen, J., Gao, Y., Lin, C., Lin, F., Wang, R., He, Y., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1622488
Metadata
- Authors
- Zhao, S., Jang, C., Liu, J., Uehara, K., Gilbert, M., Izzo, L., Zeng, X., Trefely, S., Fernandez, S., Carrer, A., Miller, K. D., Schug, Z. T., Snyder, N. W., Gade, T. P., Titchenell, P. M., Rabinowitz, J. D., & Wellen, K. E.
- Affiliations
- University of Pennsylvania (US)
- Princeton University (US)
- Veneto Institute of Molecular Medicine (IT)
- The Wistar Institute (US)
- Temple University (US)
- Corresponding author
- Wellen, Kathryn E.
- ORCID
- Venue
- Nature
- Published
- 2020-03-18
- Volume
- 579
- Issue
- 7800
- Pages
- 586-591
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7416516
- OpenAlex
- W3012090404
- Cited by
- 553
- References
- 50
- Citations by year
- 2026: 61 · 2025: 90 · 2024: 91 · 2023: 96 · 2022: 91 · 2021: 82 · 2020: 42
- FWCI
- 59.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- National Cancer Institute (T32CA115299, R01CA174761, F99CA222741, R01CA228339, T32CA009171, P30CA010815)
- National Institute of General Medical Sciences (R01GM132261, T32GM007229, K12GM081259)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116005, DP1DK113643, K01DK111715, P30DK019525, T32DK007314)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR053461)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD092630)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- dietary fructose, hepatic lipogenesis, de novo lipogenesis, gut microbiota, acetate, acetyl-CoA, ATP citrate lyase, ACSS2, fructolysis, non-alcoholic fatty liver disease, obesity, isotope tracing, lipogenic gene expression, fructose absorption
- MeSH terms
- Gastrointestinal Microbiome, Dietary Sugars, Acetates, Acetyl Coenzyme A, Acetate-CoA Ligase, Animals, ATP Citrate (pro-S)-Lyase, Fatty Acids, Fructose, Gene Expression Regulation, Isotope Labeling, Liver, Male, Substrate Specificity, Citric Acid, Hepatocytes, Lipogenesis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review